ステージIII胃癌の手術を受ける患者に対するS-1とシスプラチンの併用療法

基本情報

NCT ID

NCT00182611

ステータス

完了

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

100

治験依頼者名

National Cancer Institute (NCI)

概要

RATIONALE: Drugs used in chemotherapy, such as S-1 and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Giving chemotherapy before surgery may shrink the tumor so that it can be removed. It is not yet known whether giving S-1 together with cisplatin before surgery is more effective than surgery followed by S-1 in treating stomach cancer. PURPOSE: This randomized phase III trial is studying how well giving S-1 together with cisplatin before surgery works compared to surgery followed by S-1 in treating patients with stage III stomach cancer.

対象疾患

介入

依頼者（Sponsor）

実施施設 (7)